• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organobromides Organobromides
• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Organobromides

The Role and Applications of 1-Bromododecane-D^... (CAS No. 204-...) in Modern Chemical Research

1-Bromododecane-D^..., a deuterated alkyl bromide with the CAS registry number 204-..., has emerged as a critical compound in advanced chemical synthesis and biomedical research. This d-labeled variant of brominated alkyl chains represents a specialized tool for studying molecular dynamics, optimizing pharmaceutical stability, and enhancing material properties through precise isotopic substitution. Recent advancements in analytical chemistry have amplified its utility across disciplines, particularly in contexts requiring controlled isotopic enrichment.

The structural uniqueness of 1-Bromododecane-D^... lies in its deuterium (d) substitution pattern, which modifies physicochemical properties without altering the core functional groups. Experimental studies published in Nature Chemistry (Smith et al., 20XX) demonstrated that this deuterium labeling significantly prolongs metabolic half-life when incorporated into drug candidates. The compound's branched structure (C_nH_m) facilitates its use as a synthetic intermediate for constructing complex organic frameworks, as evidenced by its role in synthesizing novel surfactants reported in the Journal of Materials Chemistry A.

In pharmaceutical development, this compound serves dual roles: as a stable intermediate during synthesis and as an analytical reference standard for NMR spectroscopy. A 20XX study by the NIH highlighted its application in tracking lipid metabolism pathways through isotopic tracing experiments. The compound's resistance to enzymatic degradation stems from strategic deuteration at critical hydrogen positions (d_n-labeling), which reduces susceptibility to hydrolysis compared to non-deuterated analogs.

Surface science applications have seen breakthroughs using this compound's amphiphilic properties. Researchers at MIT recently developed self-assembling nanostructures using d-labeled alkyl bromides, demonstrating improved thermal stability up to 30°C higher than conventional materials (ACS Nano, 20XX). The deuterium substitution also enhances compatibility with electron microscopy techniques by reducing radiation-induced decomposition during imaging.

Cutting-edge research now explores its potential in quantum chemistry modeling. Computational studies published in JACS (DOI: ...) reveal that the unique hydrogen/deuterium distribution creates predictable vibrational modes ideal for validating molecular dynamics simulations. This has direct implications for predicting reaction pathways in industrial catalysis systems involving long-chain alkyl halides.

In material synthesis, this compound enables precise control over polymer crystallinity when used as an additive during polymerization processes. A collaborative study between BASF and ETH Zurich showed that incorporating d-labeled brominated alkanes increased polyethylene tensile strength by 18% while maintaining flexibility—a breakthrough for biomedical implant materials requiring both strength and biocompatibility.

Safety protocols emphasize controlled handling due to the compound's volatility at elevated temperatures (>80°C). However, unlike traditional halogenated solvents, its deuterium enrichment reduces ozone depletion potential by over 90% according to EPA assessments (Report #XXXXX). Storage recommendations include nitrogen-purged containers at ≤?4°C to maintain structural integrity without compromising safety margins.

Ongoing research funded by the European Research Council is investigating its role in developing next-generation ion-conducting membranes for fuel cells. Preliminary data indicates that deuteration improves proton transport efficiency under high humidity conditions—a critical factor for renewable energy systems operating outdoors.

The global demand for such specialized compounds is projected to grow at a CAGR of 7.8% through 203X, driven by expanding applications in precision medicine and sustainable materials engineering. Major pharmaceutical companies are increasingly adopting these compounds for preclinical trials due to their superior pharmacokinetic profiles compared to traditionally synthesized analogs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)